DUBLIN–(BUSINESS WIRE)–The “2020 Study of the U.S Multifocal Contact Lens Market” report has been added to ResearchAndMarkets.com’s offering. Interest in contact lenses for multifocal correction has been increasing among adults 40 and older who requi…
Category: Business
NovaBay Pharmaceuticals Expands Avenova® Consumer Marketing through Affiliate Programs and Enhanced Lifestyle Public Relations
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces expanded Avenova® consumer marketing programs designed to generate greater awareness of its antimicrobial lid and lash spray and promote online sales. No…
Aerie Pharmaceuticals Announces Successful Interim 90-Day Topline Data From Its Six-Month Mercury 3 Clinical Trial in Europe
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Worldwide Dry Eye Disease Diagnostics & Treatment Industry to 2030 – Major Drivers, Restraints, Opportunities & Threats – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Dry Eye Disease Diagnostics & Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030” report has been added to ResearchAndMarkets.com’s offering. The publisher’s report on the…
Global Electro Optical Systems Market Analysis 2020-2027: How Supply Chain Opportunities Are Changing in the High-Tech Industry Amid the Pandemic – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Electro Optical Systems – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. A pandemic of unprecedented proportions in terms of scale and speed, COVID-19 is creating a mi…
ProtoKinetix AAGP® Restores Vision in Blind Test Subjects
MARIETTA, Ohio–(BUSINESS WIRE)– #AAGP–ProtoKinetix AAGP® Restores Vision in Blind Test Subjects
Aviceda Therapeutics Appoints Biopharma and Business Veterans Chris Adams, PhD, MBA, and Nancy K. Thomason, MBA to its Board of Directors
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aviceda Therapeutics is a pre-clinical stage biotech company focused on the next generation of glycol-immune therapeutics utilizing the Glyco-Code technology to address the innate immune system and chronic non-resolvi…
Guide Dogs for the Blind Partners With Be My Eyes to Give Real-Time Video Assistance to Alumni via Innovative App
SAN RAFAEL, Calif.–(BUSINESS WIRE)– #BeMyEyesApp–Guide Dogs for the Blind partnered with Be My Eyes, an innovative app, that provides real-time video assistance to people who are visually impaired.
Aerie Pharmaceuticals Announces U.S. Food and Drug Administration Approval of its Athlone, Ireland Facility for Production of Rhopressa® (netarsudil ophthalmic solution) 0.02%
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glauco…
STAAR Surgical Announces Completion of Patient Enrollment in EVO Implantable Lens US Clinical Trial
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, is today announcing that patient enrollment for the primary st…
KalVista Pharmaceuticals Reports First Fiscal Quarter Results
CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)—- $KALV–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors,…
KalVista Pharmaceuticals to Present at Cantor Global Healthcare Conference
CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)—- $KALV–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors,…
Aura Biosciences Announces Dosing of First Patient in Phase 2 Study Evaluating Suprachoroidal Administration of AU-011 in Patients with Choroidal Melanoma
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a clinical-stage biopharmaceutical company developing a novel class of tumor targeted therapies for initial application in primary tumors such as choroidal melanoma, today announced the dosing of the…
Nouvelles données sur Enspryng (Satralizumab) de Chugai sur le risque et la sévérité des rechutes dans le trouble du spectre de la neuromyélite optique (NMOSD)
TOKYO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO : 4519) a annoncé la présentation de nouvelles données sur Enspryng® (nom générique : satralizumab [recombinaison génétique]) dans la réduction de la sévérité des rechutes dans le traitemen…
Samenvatting: Nieuwe gegevens van Chugai’s Enspryng (Satralizumab) over risico en ernst van terugval bij neuromyelitis optica spectrum disorder (NMOSD)
TOKIO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) kondigde de presentatie aan van nieuwe Enspryng® (generieke naam: satralizumab [genetische recombinatie]) gegevens over het verminderen van de ernst van terugval bij de behandeling v…
Resumen: Nuevos datos de Enspryng (satralizumab) de Chugai sobre el riesgo y la gravedad de la recaída en el trastorno del espectro óptico de la neuromielitis (NMOSD)
TOKIO–(BUSINESS WIRE)–Chugai Pharmaceutical Co., Ltd. (TOKIO:4519) ha anunciado la presentación de nuevos datos de Enspryng® (nombre genérico: satralizumab [recombinación genética]) sobre la reducción de la gravedad de las recaídas en el tratamiento …
Kala Pharmaceuticals to Host Key Opinion Leader Symposium on Unmet Need in Dry Eye Disease and Potential for EYSUVIS™
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will host a ke…
Ashvattha Therapeutics to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
REDWOOD CITY, Calif.–(BUSINESS WIRE)–Ashvattha Therapeutics, a biotech company focused on developing novel hydroxyl dendrimer therapeutics (HDTs) to treat unmet medical needs in oncology, ocular, and inflammatory diseases, today announced that Jeffre…
Immunomic Therapeutics Inc. Expands into South Korea
SEOUL–(BUSINESS WIRE)–Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, originating in the United States recently opened its first office in Sout…
Lineage Cell Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020 and at Cantor Virtual Global Healthcare Conference on September 17, 2020
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that Brian M. Culley, Chie…